• OPEN AN ACCOUNT
Indian Indices
Nifty
24,487.40 -97.65
(-0.40%)
Sensex
80,235.59 -368.49
( -0.46%)
Bank Nifty
55,043.70 -467.05
( -0.84%)
Nifty IT
34,674.30 129.65
( 0.38%)
Global Indices
Nasdaq
44,012.84 -183.78
(-0.42%)
Dow Jones
6,397.00 13.45
(-0.21%)
Hang Seng
42,778.56 958.08
(2.29%)
Nikkei 225
9,129.71 33.98
(0.37%)
Forex
USD-INR
87.65 0.09
(0.10%)
EUR-INR
102.02 -0.05
(-0.04%)
GBP-INR
117.85 0.54
(0.46%)
JPY-INR
0.59 0.00
(-0.24%)

EQUITY - MARKET SCREENER

Infinium Pharmachem Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78690
INE0MRE01011
67.838225
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
INFINIUM
47.21
399.47
EPS(TTM)
Face Value()
Div & Yield %
5.43
10
0
 

Betala Global Securities reports standalone nil net profit/loss in the December 2024 quarter
Feb 05,2025
Betala Global Securities reported no net profit/loss in the quarter ended December 2024 as against net profit of Rs 0.01 crore during the previous quarter ended December 2023. There were no Sales reported in the quarter ended December 2024 and during the previous quarter ended December 2023.